Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001664281-26-000002

Director sold 116,474 shares at an average $6.93 ($807,027)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PARMAR KUSH Director 2026-07-30 Sale −114,756 $6.93 $795,259 2,848,310 I
PARMAR KUSH Director 2026-07-31 Sale −1,718 $6.85 $11,768 2,846,592 I
Open-market sales · 116,474 sh · avg $6.93 · $807,027
Loading xslF345X06/form4-08032026_090837.xml…